NEGATIVE PRESSURE ROOM INSTALLATION BUSINESS PLAN
I. Executive Summary
Company Description
AeroShield Engineering — named for air containment (Aero) and patient protection (Shield) — is a specialized construction and engineering firm founded for a 2026 U.S. launch. We operate in the healthcare construction and life-safety sector, delivering turnkey design, installation, and certification of Airborne Infection Isolation (AII) rooms. Our core offering combines licensed mechanical and HVAC engineers with specialized project managers to deliver compliant negative-pressure rooms ready for clinical use.
We execute site surveys, engineering design, modular construction, HVAC commissioning, and regulatory certification to hospitals and clinics in a major regional medical market. What sets us apart is precise engineering paired with rapid, hospital-friendly installation timelines and documented compliance. We target acute-care hospitals and outpatient surgery centers; short-term goal is to complete initial contracts with 8–12 facilities in year one, and long-term goal is to scale to a national preferred contractor role serving 50+ facilities annually within five years.
Problem
U.S. healthcare facilities routinely lack certified negative pressure Airborne Infection Isolation (AII) rooms, leaving contagious patients insufficiently isolated. Inadequate isolation increases hospital-acquired infections and legal liability.
Many hospitals operate with outdated ventilation and facilities not built to current medical air-containment standards. There is a shortage of contractors who combine healthcare construction experience with medical air-regulation expertise, so upgrades are slow, inconsistent, and often noncompliant.
One-liner: Hospitals lack the engineering and contractor capacity to create compliant negative pressure isolation rooms.
Solution
U.S. healthcare facilities face rising airborne infection risk and lack compliant isolation infrastructure because many ventilation systems do not meet CDC and ASHRAE negative pressure standards, creating safety, regulatory, and liability exposure. Our business delivers turnkey end-to-end design and construction of Airborne Infection Isolation (AII) rooms that combine engineered negative pressure systems, medical-grade HEPA exhaust filtration, non-porous antimicrobial finishes, and integrated continuous pressure monitoring with automated airflow controls to restore compliance and protect patients and staff with minimal disruption to clinical operations. This provides a fast, compliant, single-vendor path to operational isolation rooms and reduces regulatory and safety risk.
One-liner: Turnkey AII rooms that secure airborne pathogens, maintain continuous monitoring, and retrofit with minimal clinical downtime.
Mission Statement
Our mission is to protect patients, healthcare workers, and communities by delivering the highest-quality airborne infection isolation infrastructure across the United States, engineered for regulatory certainty and rapid deployment. We commit to technical mastery and operational integrity, creating compliant negative-pressure environments that contain airborne threats at the source, one room at a time. We aim to set the national standard for safe, reliable isolation rooms that give healthcare administrators clear, measurable peace of mind.
Key Success Factors
Core strengths that drive rapid, repeatable wins in the AII room installation niche.
-
100% niche focus: exclusive dedication to AII rooms delivers deeper expertise than general contractors.
-
Senior technical team: Principal Healthcare Engineer and HVAC Commissioning Specialist ensure FGI and ASHRAE 170 compliance.
-
Fast break-even: achieved break-even in nine months, proving demand and execution efficiency.
-
Funded marketing funnel: $120,000 initial budget and falling CAC sustain a pipeline of high-value projects.
-
Turnkey delivery: end-to-end installs minimize facility downtime, preferred by busy hospitals and clinics.
Financial Summary
Financial summary for the Executive Summary: five-year launch forecast shows rapid revenue scale and positive EBITDA from year two.
Ratio | 2026 | 2027 | 2028 |
Projected Revenue | $1,469,000 | $3,166,000 | $5,265,000 |
Projected EBITDA | -$271,000 | $635,000 | $1,666,000 |
Expected ROI | IRR 5.81% / ROE 7.55% | IRR 5.81% / ROE 7.55% | IRR 5.81% / ROE 7.55% |
Financial requirements: minimum cash of $228,000 (Aug-26), total planned CAPEX $372,000, breakeven Sep-26 (9 months), payback in 28 months; project IRR 5.81% and ROE 7.55%.
Outlook: revenues grow from $1.47M in 2026 to $8.86M in 2030 with sustained profitability and disciplined COGS control.
Funding Requirements
The company requires a one-time funding injection of $610,000 to purchase service fleet and equipment, secure the regional warehouse, hire the specialized team, and provide working capital to cover operating losses through Aug-26.
Categories | Amount, USD |
Product Development | $0 |
Marketing (launch campaign) | $0 |
Operations | $0 |
Staffing & Hiring | $0 |
Regional warehouse setup & deposits | $0 |
Service fleet & equipment (capital expenditures) | $382,000 |
Other one-time capex | $0 |
Working capital | $228,000 |
Total funding required | $610,000 |